Compounds > ezetimibe
Page last updated: 2024-09-04

ezetimibe and HIV-Associated Lipodystrophy Syndrome

ezetimibe has been researched along with HIV-Associated Lipodystrophy Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alonso-Villaverde, C; Aragonés, G; Coll, B; Masana, L; Parra, S1

Trials

1 trial(s) available for ezetimibe and HIV-Associated Lipodystrophy Syndrome

ArticleYear
Ezetimibe effectively decreases LDL-cholesterol in HIV-infected patients.
    AIDS (London, England), 2006, Aug-01, Volume: 20, Issue:12

    Topics: Adult; Anticholesteremic Agents; Antiretroviral Therapy, Highly Active; Azetidines; Cholesterol; Cholesterol, LDL; Endothelium; Ezetimibe; Fatty Acids, Monounsaturated; Fluvastatin; HIV-Associated Lipodystrophy Syndrome; Humans; Indoles; Treatment Outcome

2006